Evidence map›Paper›PMID 33899087›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2022

Validation of HVLT-R, BVMT-R, and RBANS Learning Slope Scores along the Alzheimer's Continuum.

Dustin B Hammers, Kayla Suhrie, Ava Dixon, Brian D Gradwohl, Kevin Duff, Robert J Spencer

Abstract read
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Evaluating practice effects across learning trials - ceiling effects or something more?Journal of clinical and experimental neuropsychology · 2024
    Article
  5. Article
  6. Learning slopes in early-onset Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Validation of and Demographically Adjusted Normative Data for the Learning Ratio Derived from the RAVLT in Robustly Intact Older Adults.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dustin B HammersDepartment of Neurology, Center for Alzheimer's Care, Imaging, and Research, University of Utah, Salt Lake City, UT, USA.
Kayla SuhrieDepartment of Neurology, Center for Alzheimer's Care, Imaging, and Research, University of Utah, Salt Lake City, UT, USA.
Ava DixonDepartment of Neurology, Center for Alzheimer's Care, Imaging, and Research, University of Utah, Salt Lake City, UT, USA.
Brian D GradwohlMental Health Service, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Kevin DuffDepartment of Neurology, Center for Alzheimer's Care, Imaging, and Research, University of Utah, Salt Lake City, UT, USA.
Robert J SpencerMental Health Service, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.

Funding

Enriching clinical trials requiring amyloid positivity with practice effectsR01AG055428 · NIA · UNIVERSITY OF UTAH · PI DUFF, KEVIN M, HOFFMAN, JOHN M · 2017 to 2021
$3.6M
Cognitive training and practice effects in MCIR01AG045163 · NIA · UNIVERSITY OF UTAH · PI DUFF, KEVIN M · 2014 to 2018
$2.2M
Predicting dementia with practice effectsK23AG028417 · NIA · UNIVERSITY OF UTAH · PI DUFF, KEVIN M · 2007 to 2011
$707k
Predicting Decline in Mild Cognitive ImpairmentR03AG025850 · NIA · UNIVERSITY OF IOWA · PI DUFF, KEVIN M · 2005 to 2006
$120k
NIA NIH HHS K23 AG028417NIA NIH HHS R01 AG045163NIA NIH HHS R01 AG055428NIA NIH HHS R03 AG025850
6 · The paper itself

Abstract

backgroundThe learning ratio (LR) is a novel learning slope score that has been developed to reduce the inherent competition between the first trial and subsequent trials in traditional learning slopes. In essence, the LR is the number of items learned after the first trial divided by the number of items yet to be learned. Criterion and convergent validation of this LR score is warranted to understand its sensitivity along the Alzheimer's disease (AD) continuum.

methodThe LR metric was calculated for 123 participants from standard measures of memory, including the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) list learning, and RBANS story memory. All participants were categorized as normal cognition, mild cognitive impairment (MCI), or AD. LR performances were compared between groups, among other standard memory measures, and with regards to how well they discriminated cognitively impaired from unimpaired samples-and within diagnostic subgroups.

resultsLower LR scores were observed for the MCI and AD groups than the normal cognition group, with the AD group performing worse than the MCI group for several slope calculations. Lower LR scores were also consistently associated with poorer performances on traditional memory measures. LR scores further displayed excellent receiver operator characteristics when differentiating those with and without cognitive impairment-and MCI from normal cognition. Overall, LR scores consistently outperformed traditional learning slope calculations across all analyses.

conclusionsThis LR score is sensitive to memory dysfunction along the AD continuum, and results offer criterion and convergent validity for use of the LR metric to understand learning capacity.

Indexed as

Alzheimer DiseaseCognitive DysfunctionCognitionHumansLearningNeuropsychological TestsAlzheimer’s diseaseLearningLearning slopeMemoryMild cognitive impairment

Identifiers

PMID33899087
PMCPMC11484609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.